Our work therefore identifies that in breast cancer mouse models, a mechanism of chemoresistance, where chemotherapy-naïve cancer cells enriched in the brain, can undergo VM and concomitantly overexpress BCRP, which protects them against chemotherapy. This evidence concerns the gene ABCG2 and breast carcinoma.